Skip to main content
. 2017 Mar 2;10(1):230–234. doi: 10.1159/000456540

Table 1.

Laboratory values

Reference range Before treatment After Nivolumab (27 days) After Nivolumab (about 3 months)
HbA1c <6.4% unavailable1 7.2% 9.2%
TSH 0.27–4.2 IU/mL 1.3 1.9 35.56
Anti-GAD antibody <1 U/mL unavailable 26.6 unavailable
Anti-TPO antibody <9 IU/mL unavailable 17 unavailable
1

Fasting blood glucose 91 mg/dL at baseline.